607
Views
0
CrossRef citations to date
0
Altmetric
Review Article

What is the extent of reliability and validity evidence for screening tools for cognitive and behavioral change in people with ALS? A systematic review

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 06 Dec 2023, Accepted 28 Jan 2024, Published online: 28 Feb 2024

References

  • Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 2005;65:586–90.
  • Abrahams S. Neuropsychological impairment in amyotrophic lateral sclerosis – frontotemporal spectrum disorder. Nat Rev Neurol. 2023;19:655–67.
  • Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis – frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
  • Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170532/pdf/awr179.pdf
  • Simon N, Goldstein LH. Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: a systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener. 2018;20:1–11.
  • Taule T, Søvik M, Lein RK, Wehling E, Aßmus J, Rekand T. Psychometric properties of cognitive assessment in amyotrophic lateral sclerosis: a systematic review. Patient Relat Outcome Meas. 2020; 11:181–94.
  • Gosselt IK, Nijboer TCW, Van Es MA. An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotroph Lateral Scler Frontotemporal Degener. 2020; 21:324–36.
  • Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
  • Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O’Sullivan M, et al. Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI). Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:68–73.
  • Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBSTM). Amyotroph Lateral Scler. 2010;11:303–11.
  • Mioshi E, Hsieh S, Caga J, Ramsey E, Chen K, Lillo P, et al. A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:298–304.
  • Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s cognitive examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36:242–50.
  • Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078–85.
  • Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: A frontal assessment battery at bedside. Neurology 2000;55:1621–6.
  • Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
  • Hsieh S, McGrory S, Leslie F, Dawson K, Ahmed S, Butler CR, et al. The Mini-Addenbrooke’s Cognitive Examination: A new assessment tool for dementia. Dement Geriatr Cogn Disord. 2015;39:1–11.
  • Hsieh S, Caga J, Leslie FVC, Shibata M, Daveson N, Foxe D, et al. Cognitive and behavioral symptoms in ALSFTD: detection, differentiation, and progression. J Geriatr Psychiatry Neurol. 2016;29:3–10. Available at: https://doi.org/10.1177/0891988715598232
  • Raaphorst J, Beeldman E, Schmand B, Berkhout J, Linssen WHJP, Van Den Berg LH, et al. The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS. Neurology 2012;79:1377–83.
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. Available from: http://www.prisma-statement.
  • Streiner DL, Norman GR, Cairney J. Health measurement scales. A practical guide to their development and use. 4th ed. New York: Oxford University Press; 2014.
  • Bogduk N. On understanding the validity of diagnostic tests. Interventional Pain Medicine. 2022;1:100127.
  • Rossi TM. Study design synopsis: Clinical validation of diagnostic tests. Equine Vet J. 2020;53:410–3.
  • Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, Faini A, et al. The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:489–98.
  • Ye S, Ji Y, Li C, He J, Liu X, Fan D. The Edinburgh Cognitive and Behavioural ALS Screen in a Chinese Amyotrophic Lateral Sclerosis Population. PLoS One. 2016;11:e0155496. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873026/pdf/pone.0155496.pdf
  • Mora JS, Salas T, Fernández MC, Rodríguez-Castillo V, Marín S, Chaverri D, et al. Spanish adaptation of the edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:74–9.
  • Kourtesis P, Christidi F, Margioti E, Demenega C, Rentzos M, Evdokimidis I, et al. The Edinburgh cognitive and behavioral amyotrophic lateral sclerosis screen (ECAS): sensitivity in differentiating between ALS and Alzheimer’s disease in a Greek population. Amyotroph Lateral Scler Frontotemporal Degener. 2019;21:78–85.
  • Mojtabavi H, Nafissi S, Mahmoodi-Bakhtiari B, Fathi D, Fatehi F. Persian adaptation of Edinburgh Cognitive and Behavioural Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:426–33.
  • Watanabe Y, Beeldman E, Raaphorst J, Izumi Y, Yoshino H, Masuda M, et al. Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J). J Neurol Sci. 2016;367:51–5.
  • Kacem I, Abida Y, Ferchichi W, Mrabet S, Sghaier I, Gharbi A, et al. Arabic adaptation of the Edinburgh cognitive and behavioural Amyotrophic lateral sclerosis screen (ECAS-AR). Rev Neurol (Paris). 2022;178:817–25.
  • Lee J, Kim A, Choi SJ, Cho E, Seo J, Oh SI, et al. Development and validation of the Korean Version of the Edinburgh cognitive and behavioral amyotrophic lateral sclerosis Screen (ECAS-K). J Clin Neurol. 2023;19:454–9.
  • Fazio R, Soósová N, Bak T, Růžička E, Bezdicek O. A normative study of the Czech Edinburgh Cognitive and Behavioural ALS Screen (ECAS): a brief report. Clin Neuropsychol. 2021;35:S65–S72.
  • Albertyn CH, Hardy A, Bakker LA, Hlangani M, Van Der Walt K, Zeilinga B, et al. Adaptation and norming of the Edinburgh Cognitive and behavioural amyotrophic lateral sclerosis screen (ECAS) for three language groups in South Africa. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:532–41.
  • Lulé D, Burkhardt C, Abdulla S, Böhm S, Kollewe K, Uttner I, et al. The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: A cross-sectional comparison of established screening tools in a German-Swiss population. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:16–23.
  • Aiello EN, Solca F, Greco LC, La Tona A, Torre S, Carelli L, et al. Standardization of the Italian ALS-CBSTM Caregiver Behavioral Questionnaire. Front Psychol. 2023;13:1107001.
  • Iazzolino B, Pain D, Laura P, Aiello EN, Gallucci M, Radici A, et al. Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:81–6.
  • Burke T, Pinto-Grau M, Lonergan K, Bede P, O’Sullivan M, Heverin M, et al. A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival. Ann Clin Transl Neurol. 2017;4:305–17.
  • Rahimzadeh Goradel R, Sattarpour R, Hooshyari Z, Taebi M, Ghavampour A, Jazani MR, et al. Examining the validity and reliability of the Persian version of the MiND-B questionnaire in ALS patients. Brain Behav 2023;13(9):e3167.
  • Aiello EN, Iazzolino B, Pain D, Peotta L, Palumbo F, Radici A, et al. The diagnostic value of the Italian version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:527–31.
  • Beeldman E, Govaarts R, de Visser M, van Es MA, Pijnenburg YAL, Schmand BA, et al. Screening for cognition in amyotrophic lateral sclerosis: test characteristics of a new screen. J Neurol. 2021;268:2533–40.
  • Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, et al. Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:172–9.
  • Okeh UM, Okoro CN. Evaluating measures of indicators of diagnostic test performance: fundamental meanings and formulars. J Biom Biostat 2012;03:1–10.
  • Aiello EN, Solca F, Greco LC, Torre S, Carelli L, Morelli C, et al. Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBSTM) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients. J Neurol. 2023;270:4090–5.
  • Branco LMT, Zanao T, De Rezende TJ, Casseb RF, Balthazar MF, Woolley SC, et al. Transcultural validation of the ALS-CBS cognitive section for the Brazilian population. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:60–7.
  • Greco LC, Lizio A, Casiraghi J, Ada Sansone V, Tremolizzo L, Riva N, et al. A preliminary comparison between ECAS and ALS-CBS in classifying cognitive-behavioural phenotypes in a cohort of non-demented amyotrophic lateral sclerosis patients. J Neurol. 2021;269:1899–904.
  • Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, et al. Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS Cohort. Neurology. 2016;86:813–20.
  • Tremolizzo L, Lizio A, Santangelo G, Diamanti S, Lunetta C, Gerardi F, et al. ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability. Neurol Sci. 2020;41:835–41.
  • Turon-Sans J, Gascon-Bayarri J, Reñé R, Rico I, Gámez C, Paipa A, et al. Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:221–7.
  • Murphy J, Ahmed F, Lomen-Hoerth C. The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:24–30.
  • Watanabe Y, Ogino M, Ichikawa H, Hanajima R, Nakashima K. The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) for Japanese ALS and FTD patients. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:66–72.
  • De Icaza Valenzuela MM, Bak TH, Pal S, Abrahams S. The Edinburgh Cognitive and Behavioral ALS screen: relationship to age, education, IQ and the Addenbrooke’s Cognitive Examination-III. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:585–90.
  • Saxon JA, Thompson JC, Harris JM, Ealing J, Hamdalla H, Chaouch A, et al. The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:606–13.
  • Pinto-Grau M, Costello E, O'Connor S, Elamin M, Burke T, Heverin M, et al. Assessing behavioural changes in ALS: cross-validation of ALS-specific measures. J Neurol. 2017;264:1397–401. Available at: https://doi.org/10.1007/s00415-017-8536-6.pdf
  • Grace J, Malloy P. Frontal systems behavior scale: professional manual. Lutz, Florida: Psychological Assessment Resources Inc; 2001.
  • Kertesz A, Davidson W, Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29–36.
  • Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C. Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract. 2017;7:488–98.
  • Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, et al. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:19–27.
  • Díaz JL, Mondragón H, Sancho J, Aguilar EJ, Servera E. Relationship between cognitive-behavioral impairment and clinical and functional parameters in ALS and reliability of the Edinburgh Cognitive and Behavioural ALS screen to assess ALS: preliminary findings. Cogn Behav Neurol. 2019;32:185–92.
  • Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 2000;55:1613–20.
  • Kertesz A, Nadkarni N, Davidson W, Thomas A. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000;6:460–8.
  • Weigl E. On the psychology of so-called processes of abstraction. J Abnorm Soc Psychol. 1941;36:3–33.
  • Kay J, Lesser R, Coltheart M. Psycholinguistic assessments of language processing in aphasia (PALPA). East Sussex: Lawrence Erlbaum Associates; 1992.